{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:48:33Z","timestamp":1791110913620,"version":"4.1.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014717","name":"Youth Science Fund Project","doi-asserted-by":"publisher","award":["BK20240199"],"award-info":[{"award-number":["BK20240199"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273786"],"award-info":[{"award-number":["82273786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473848"],"award-info":[{"award-number":["82473848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["1132210021"],"award-info":[{"award-number":["1132210021"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632025TD02"],"award-info":[{"award-number":["2632025TD02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010035","name":"Outstanding Youth Foundation of Jiangsu Province of China","doi-asserted-by":"publisher","award":["BK20240199"],"award-info":[{"award-number":["BK20240199"]}],"id":[{"id":"10.13039\/501100010035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118623","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:27:36Z","timestamp":1769560056000},"page":"118623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Small-molecule modulators of the necroptotic pathway: A medicinal chemistry perspective"],"prefix":"10.1016","volume":"306","author":[{"given":"De-Chang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Dong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-2538","authenticated-orcid":false,"given":"Xiao-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118623_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/cr.2013.91","article-title":"Mlkl knockout mice demonstrate the indispensable role of mlkl in necroptosis","volume":"23","author":"Wu","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib9","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/acs.jmedchem.2c01621","article-title":"From (Tool)Bench to bedside: the potential of necroptosis inhibitors","volume":"66","author":"Gardner","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib10","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1016\/j.bmcl.2005.07.077","article-title":"Structure-activity relationship study of novel necroptosis inhibitors","volume":"15","author":"Teng","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/bph.14653","article-title":"Identification of the raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3","volume":"176","author":"Chen","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib12","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.jmedchem.1c01572","article-title":"Targeting regulated cell death with pharmacological small molecules: an update on autophagy-dependent cell death, ferroptosis, and necroptosis in cancer","volume":"65","author":"Wu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/cdd.2011.164","article-title":"Many stimuli pull the necrotic trigger, an overview","volume":"19","author":"Vanlangenakker","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118623_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling","volume":"28","author":"Ch\u00e9dotal","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118623_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118623_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ncb2362","article-title":"Caspase 8 inhibits programmed necrosis by processing CYLD","volume":"13","author":"O'Donnell","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib18","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1074\/jbc.M112.435545","article-title":"Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling","volume":"288","author":"Chen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib21","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41467-020-16887-1","article-title":"MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis","volume":"11","author":"Samson","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","article-title":"Roles of RIPK3 in necroptosis, cell signaling, and disease","volume":"54","author":"Morgan","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41419-019-1396-5","article-title":"Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling","volume":"10","author":"F\u00fcllsack","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1083\/jcb.200904158","article-title":"Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment","volume":"187","author":"Geserick","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib27","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/cdd.2012.90","article-title":"TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation","volume":"19","author":"Jouan-Lanhouet","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118623_bib28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.chom.2019.09.004","article-title":"DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA","volume":"26","author":"Upton","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.118623_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2016.05.011","article-title":"RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus","volume":"20","author":"Nogusa","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.118623_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2019.05.022","article-title":"TAM kinases promote necroptosis by regulating oligomerization of MLKL","volume":"75","author":"Najafov","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/acschembio.3c00603","article-title":"Acylation of MLKL impacts its function in necroptosis","volume":"19","author":"Pradhan","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166613","article-title":"Necroptosis signaling and NLRP3 inflammasome cross-talking in epithelium facilitate Pseudomonas aeruginosa mediated lung injury","volume":"1869","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib33","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in alzheimer's disease","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118623_bib35","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in parkinson's disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"Embo j"},{"key":"10.1016\/j.ejmech.2026.118623_bib36","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.celrep.2018.01.089","article-title":"Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in parkinson's disease models","volume":"22","author":"Iannielli","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.aaf6803","article-title":"RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS","volume":"353","author":"Ito","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118623_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00395-012-0270-8","article-title":"Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo","volume":"107","author":"Oerlemans","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejmech.2026.118623_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cvr\/cvu146","article-title":"RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction","volume":"103","author":"Luedde","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600224","article-title":"Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis","volume":"2","author":"Karunakaran","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118623_bib48","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.dld.2017.08.017","article-title":"RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells","volume":"49","author":"Negroni","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2014.09.016","article-title":"The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair","volume":"41","author":"Moriwaki","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.118623_bib66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-019-1809-3","article-title":"RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis","volume":"17","author":"Jhun","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2018.02.017","article-title":"Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis","author":"Bolognese","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.ejmech.2026.118623_bib68","doi-asserted-by":"crossref","first-page":"51613","DOI":"10.1074\/jbc.M305633200","article-title":"A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses","volume":"278","author":"Chan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2017.03.011","article-title":"RIPK3 restricts viral pathogenesis via cell death-independent neuroinflammation","volume":"169","author":"Daniels","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006326","article-title":"RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection","volume":"13","author":"Downey","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.118623_bib71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fob.2014.08.007","article-title":"Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure","volume":"4","author":"Takemoto","year":"2014","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejmech.2026.118623_bib72","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4149\/neo_2015_071","article-title":"Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer","volume":"62","author":"Feng","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejmech.2026.118623_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.240","article-title":"Absence of RIPK3 predicts necroptosis resistance in malignant melanoma","volume":"6","author":"Geserick","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib52","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","article-title":"Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics","volume":"25","author":"Koo","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib74","first-page":"1539","article-title":"Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients","volume":"6","author":"He","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2026.118623_bib50","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1007\/s13277-016-5229-1","article-title":"Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner","volume":"37","author":"Ertao","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejmech.2026.118623_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","article-title":"Necroptosis in the pathophysiology of disease","volume":"190","author":"Khoury","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2026.118623_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ki.2011.450","article-title":"Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia\/reperfusion injury","volume":"81","author":"Linkermann","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2026.118623_bib42","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.1073\/pnas.1305538110","article-title":"Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury","volume":"110","author":"Linkermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118623_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175037","article-title":"Necrosulfonamide improves post-resuscitation myocardial dysfunction via inhibiting pyroptosis and necroptosis in a rat model of cardiac arrest","volume":"926","author":"He","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ijmm.2021.4922","article-title":"The potential role of necroptosis in clinical diseases","volume":"47","author":"Dai","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fcell.2020.00502","article-title":"RIPK3: a new player in renal fibrosis","volume":"8","author":"Shi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1165\/rcmb.2017-0034OC","article-title":"Involvement of alveolar epithelial cell necroptosis in idiopathic pulmonary fibrosis pathogenesis","volume":"59","author":"Lee","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107717","article-title":"A decade of cell death studies: breathing new life into necroptosis","volume":"220","author":"Khan","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118623_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050820","article-title":"The induction mechanism of ferroptosis, necroptosis, and pyroptosis in inflammatory bowel disease, colorectal cancer, and intestinal injury","volume":"13","author":"Zhou","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118623_bib51","first-page":"15035","article-title":"Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer","volume":"8","author":"Ruan","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2026.118623_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1299302","article-title":"Pro-necrotic molecules impact local immunosurveillance in human breast cancer","volume":"6","author":"Stoll","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejmech.2026.118623_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1533034616655909","article-title":"Association of mixed lineage kinase domain-like protein expression with prognosis in patients with Colon cancer","volume":"16","author":"Li","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.118623_bib56","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-08-4079","article-title":"The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma","volume":"69","author":"Park","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib57","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/carcin\/bgt143","article-title":"RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2026.118623_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature17403","article-title":"The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression","volume":"532","author":"Seifert","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib59","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/cncr.28144","article-title":"Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma","volume":"119","author":"Colbert","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2026.118623_bib60","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.4161\/cc.8.20.9699","article-title":"Inflammation: a driving force speeds cancer metastasis","volume":"8","author":"Wu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2026.118623_bib61","first-page":"3174","article-title":"Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice","volume":"5","author":"Liu","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2015.01.002","article-title":"RIP1\/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice","volume":"17","author":"Huang","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.118623_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41422-022-00775-y","article-title":"SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses","volume":"33","author":"Li","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117196","article-title":"Recognition of necroptosis: from molecular mechanisms to detection methods","volume":"178","author":"Zhu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118623_bib76","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","article-title":"Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target","volume":"19","author":"Mifflin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118623_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-021-02468-0","article-title":"A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis","volume":"23","author":"Weisel","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2026.118623_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib80","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1073\/pnas.1813582116","article-title":"Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118623_bib81","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/CM9.0000000000000225","article-title":"Plasma levels of receptor interacting protein kinase-3 correlated with coronary artery disease","volume":"132","author":"Hu","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ejmech.2026.118623_bib82","article-title":"Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acute decompensation of cirrhosis","author":"Verma","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2026.118623_bib83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2020.06.039","article-title":"Plasma concentration of receptor-interacting protein kinase-3 as a potential biomarker for diagnosis and prognosis in heart failure","volume":"509","author":"Hu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmech.2026.118623_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41425-6","article-title":"Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury","volume":"13","author":"Kondo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70424","article-title":"Evaluation of prognostic implication of serum mixed lineage kinase domain-like protein in acute primary supratentorial intracerebral hemorrhage: a multicenter prospective cohort study","volume":"15","author":"Ma","year":"2025","journal-title":"Brain Behav"},{"key":"10.1016\/j.ejmech.2026.118623_bib86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/cdd.2015.70","article-title":"Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis","volume":"23","author":"Rodriguez","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118623_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112886","article-title":"Serum HMGB-1 released by ferroptosis and necroptosis as a novel potential biomarker for systemic lupus erythematosus","volume":"140","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib88","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","article-title":"Activation of necroptosis in multiple sclerosis","volume":"10","author":"Ofengeim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib89","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1078-0432.CCR-18-3683","article-title":"Somatic epigenetic silencing of RIPK3 inactivates necroptosis and contributes to chemoresistance in malignant mesothelioma","volume":"27","author":"Tan","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119850","article-title":"A prospective cohort study regarding usability of serum RIPK3 as a biomarker in relation to early hematoma growth and neurological outcomes after acute intracerebral hemorrhage","volume":"562","author":"Li","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmech.2026.118623_bib91","doi-asserted-by":"crossref","first-page":"eadi1782","DOI":"10.1126\/sciadv.adi1782","article-title":"RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118623_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083863","article-title":"Epigenetic inactivation of RIPK3-Dependent necroptosis augments Cisplatin chemoresistance in human osteosarcoma","volume":"26","author":"Sharma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118623_bib93","article-title":"Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.118623_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010348","article-title":"Comprehensive analysis of PANoptosis-Related gene signature of ulcerative colitis","volume":"25","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118623_bib95","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00011-024-01877-6","article-title":"Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis","volume":"73","author":"Zheng","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.826904","article-title":"Necroptosis and viral myocarditis: tumor necrosis factor \u03b1 as a novel biomarker for the diagnosis of viral myocarditis","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108334","article-title":"The immune microenvironment related biomarker CCL18 for patients with gout by comprehensive analysis","volume":"115","author":"Zhang","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib98","article-title":"Data-driven analysis that integrates bioinformatics and machine learning uncovers PANoptosis-related diagnostic genes in early pediatric septic shock","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.118623_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.953997","article-title":"A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer","volume":"13","author":"Xin","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.118623_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1027741","article-title":"Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.118623_bib101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s41065-024-00335-x","article-title":"Comprehensive analysis of a necroptosis-associated diagnostic signature for myelodysplastic syndromes based on single-cell RNA-seq and bulk RNA-seq","volume":"161","author":"Zhang","year":"2024","journal-title":"Hereditas"},{"key":"10.1016\/j.ejmech.2026.118623_bib102","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12920-025-02241-1","article-title":"Single-cell RNA-seq combined with bulk RNA-seq analysis identifies necroptosis-related genes as therapeutic targets for periodontitis","volume":"18","author":"Zhu","year":"2025","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ejmech.2026.118623_bib103","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1013094","article-title":"Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma","volume":"13","author":"Wan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","article-title":"Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes","volume":"103","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib106","doi-asserted-by":"crossref","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","article-title":"Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL","volume":"288","author":"Kaiser","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib107","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1038\/s41598-017-06088-0","article-title":"Hypoxia-inducible factor-1 alpha is involved in RIP-induced necroptosis caused by in vitro and in vivo ischemic brain injury","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib108","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity","volume":"56","author":"Mandal","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113327","article-title":"Ring closure strategy leads to potent RIPK3 inhibitors","volume":"217","author":"Wu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.606119","article-title":"Discovery of a potent RIPK3 inhibitor for the amelioration of necroptosis-associated inflammatory injury","volume":"8","author":"Xia","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.it.2017.11.002","article-title":"ZBP1: innate sensor regulating cell death and inflammation","volume":"39","author":"Kuriakose","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib112","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41586-024-07265-8","article-title":"Necroptosis blockade prevents lung injury in severe influenza","volume":"628","author":"Gautam","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib113","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.9b00611","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128084","article-title":"Enantiomeric profiling of a chiral benzothiazole necroptosis inhibitor","volume":"43","author":"Zhu","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109262","article-title":"RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation","volume":"112","author":"Xu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib116","first-page":"1","article-title":"HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis","volume":"50","author":"Park","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117716","article-title":"Discovery of quinazoline derivatives as RIPK3 inhibitors that switch cell death from necroptosis to apoptosis for psoriasis treatment","volume":"294","author":"Hong","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib118","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acsmedchemlett.9b00065","article-title":"Identification of RIPK3 type II inhibitors using high-throughput mechanistic studies in hit triage","volume":"11","author":"Hart","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118623_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.241","article-title":"The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113947","article-title":"The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases","volume":"177","author":"Qin","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib121","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1038\/s41467-021-27032-x","article-title":"Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis","volume":"12","author":"Meng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib122","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2013.08.044","article-title":"Structural insights into RIP3-mediated necroptotic signaling","volume":"5","author":"Xie","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aar2188","article-title":"Kinase domain dimerization drives RIPK3-dependent necroptosis","volume":"11","author":"Raju","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.118623_bib124","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1038\/s41467-025-59432-8","article-title":"Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro","volume":"16","author":"Su","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-024-02670-z","article-title":"Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study","volume":"25","author":"Clot","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib126","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118623_bib127","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-017-0245-7","article-title":"RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)","volume":"9","author":"Martens","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib129","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/ml400382p","article-title":"Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis","volume":"4","author":"Harris","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118623_bib130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.apsb.2023.10.021","article-title":"Structure-based development of potent and selective type-II kinase inhibitors of RIPK1","volume":"14","author":"Qin","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118623_bib131","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1021\/acs.jmedchem.8b01652","article-title":"Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model","volume":"61","author":"Li","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib132","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-019-1735-6","article-title":"Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis","volume":"10","author":"Hou","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114036","article-title":"Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity","volume":"228","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib134","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.2022017262","article-title":"A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis","volume":"141","author":"Yu","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118623_bib135","doi-asserted-by":"crossref","first-page":"14957","DOI":"10.1021\/acs.jmedchem.2c01478","article-title":"Discovery of a trifluoromethoxy cyclopentanone benzothiazole receptor-interacting protein kinase 1 inhibitor as the treatment for alzheimer's disease","volume":"65","author":"Sun","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib136","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1021\/acs.jmedchem.3c00197","article-title":"Targeting receptor-interacting protein kinase 1 by novel benzothiazole derivatives: treatment of Acute lung injury through the necroptosis pathway","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib137","doi-asserted-by":"crossref","first-page":"15288","DOI":"10.1021\/acs.jmedchem.3c01351","article-title":"Insight from linker investigations: discovery of a novel phenylbenzothiazole necroptosis inhibitor targeting receptor-interacting protein kinase 1 (RIPK1) from a phenoxybenzothiazole compound with dual RIPK1\/3 targeting activity","volume":"66","author":"Fang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib138","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41401-022-00993-5","article-title":"Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.118623_bib139","doi-asserted-by":"crossref","first-page":"21766","DOI":"10.1021\/acs.jmedchem.5c02124","article-title":"Discovery of a 1H-Pyrazol-3-Amine derivative as a novel, selective, and orally available RIPK1 inhibitor for the treatment of inflammatory disease","volume":"68","author":"Tao","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114528","article-title":"The bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases","volume":"161","author":"Piao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118623_bib141","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/intimm\/dxac061","article-title":"Repurposing crizotinib to target RIPK1-dependent cell death","volume":"35","author":"Yu","year":"2023","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib142","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcdb.2020.06.014","article-title":"RIPK protein kinase family: atypical lives of typical kinases","volume":"109","author":"Cuny","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib143","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10495-023-01905-6","article-title":"Necroptosis inhibitors: mechanisms of action and therapeutic potential","volume":"29","author":"Zhou","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2026.118623_bib144","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41420-022-00929-2","article-title":"Inhibition of RIPK1 by ZJU-37 promotes oligodendrocyte progenitor proliferation and remyelination via NF-\u03baB pathway","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2026.118623_bib146","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/jm061016o","article-title":"Structure-activity relationship study of tricyclic necroptosis inhibitors","volume":"50","author":"Jagtap","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib147","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.bmcl.2012.06.098","article-title":"Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability","volume":"22","author":"Choi","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib148","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1016\/j.bmcl.2007.10.024","article-title":"Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors","volume":"17","author":"Teng","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib149","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.bmcl.2008.04.048","article-title":"Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors","volume":"18","author":"Teng","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.str.2013.01.016","article-title":"Structural basis of RIP1 inhibition by necrostatins","volume":"21","author":"Xie","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.118623_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10091347","article-title":"Necrostatin-1 prevents ferroptosis in a RIPK1- and IDO-Independent manner in hepatocellular carcinoma","volume":"10","author":"Yuk","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.118623_bib152","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1021\/acs.jmedchem.5b01898","article-title":"DNA-Encoded Library screening identifies Benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors","volume":"59","author":"Harris","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib153","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib154","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s11010-021-04136-y","article-title":"Pleiotropic, non-cell death-associated effects of inhibitors of receptor-interacting protein kinase 1 in the heart","volume":"476","author":"Horvath","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.118623_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.365","article-title":"Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers","volume":"5","author":"Weisel","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejmech.2026.118623_bib156","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000680","article-title":"A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis","volume":"8","author":"Weisel","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.ejmech.2026.118623_bib157","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/acs.jmedchem.7b01647","article-title":"Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships","volume":"61","author":"Yoshikawa","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117385","article-title":"Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agents","volume":"91","author":"Tang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116304","article-title":"Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsy","volume":"269","author":"Jiang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113484","article-title":"Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors","volume":"220","author":"Xia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114345","article-title":"Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors","volume":"236","author":"Hao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib162","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bmcl.2019.04.014","article-title":"Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group","volume":"29","author":"Hamilton","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118623_bib163","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","article-title":"RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases","volume":"27","author":"Patel","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118623_bib164","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsmedchemlett.9b00108","article-title":"Identification of a RIP1 kinase inhibitor clinical candidate (GSK3145095) for the treatment of pancreatic cancer","volume":"10","author":"Harris","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118623_bib165","doi-asserted-by":"crossref","first-page":"21049","DOI":"10.1021\/acs.jmedchem.4c01731","article-title":"Polypharmacological drug design guided by integrating phenotypic and restricted fragment docking strategies","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib166","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1021\/acs.jmedchem.9b00318","article-title":"Discovery and lead-optimization of 4,5-Dihydropyrazoles as mono-kinase selective, orally bioavailable and efficacious inhibitors of receptor interacting protein 1 (RIP1) kinase","volume":"62","author":"Harris","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib167","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccell.2020.09.020","article-title":"RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer","volume":"38","author":"Wang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117884","article-title":"Targeting RIPK1-mediated necroptosis, oxidative stress, and ferroptosis: a novel multitarget therapy for ischemic stroke","volume":"296","author":"Song","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib169","article-title":"Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model","author":"Shan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118623_bib170","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1038\/s41467-022-34692-w","article-title":"Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib171","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.jmedchem.3c02102","article-title":"From hit to lead: structure-based optimization of novel selective inhibitors of receptor-interacting protein kinase 1 (RIPK1) for the treatment of inflammatory diseases","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib172","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55006-2","article-title":"Development of a RIPK1 degrader to enhance antitumor immunity","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib173","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c00773","article-title":"Design, optimization, and development of RIPK1 degraders with improved pharmacokinetic and pharmacodynamic properties","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib174","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.immuni.2024.04.025","article-title":"A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death","volume":"57","author":"Mannion","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.118623_bib175","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1021\/acs.jmedchem.5c01340","article-title":"Development of potent and selective RIPK1 degraders targeting its nonenzymatic function for cancer treatment","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib176","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-022-05524-y","article-title":"TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1\/RIPK3\/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib177","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118623_bib178","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1039\/C3MD00278K","article-title":"Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein","volume":"5","author":"Liao","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2026.118623_bib179","doi-asserted-by":"crossref","first-page":"33272","DOI":"10.1073\/pnas.2017406117","article-title":"Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis","volume":"117","author":"Rubbelke","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118623_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117659","article-title":"Design, synthesis and anti-necroptosis activity of fused heterocyclic MLKL inhibitors","volume":"102","author":"Tang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib181","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation","volume":"11","author":"Duan","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118623_bib182","article-title":"Necrosulfonamide alleviates acute brain injury of intracerebral hemorrhage via inhibiting inflammation and necroptosis","volume":"15","author":"Zhang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118623_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115338","article-title":"Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis","volume":"206","author":"Yang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib184","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ejmech.2026.118623_bib185","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1039\/C7CC00667E","article-title":"Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein","volume":"53","author":"Yan","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118623_bib186","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1021\/acs.jmedchem.2c00548","article-title":"Discovery of a new class of uracil derivatives as potential mixed lineage kinase domain-like protein (MLKL) inhibitors","volume":"65","author":"Cui","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib187","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-025-02763-8","article-title":"Apomorphine is a novel necroptosis inhibitor targeting mixed lineage kinase domain-like protein oligomerization","volume":"11","author":"Han","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2026.118623_bib188","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1073\/pnas.1408987111","article-title":"Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death","volume":"111","author":"Hildebrand","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118623_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165983","article-title":"ATP-Competitive MLKL binders have no functional impact on necroptosis","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118623_bib190","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1021\/acschembio.0c00482","article-title":"Potent inhibition of necroptosis by simultaneously targeting multiple effectors of the pathway","volume":"15","author":"Pierotti","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118623_bib191","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1021\/acs.jmedchem.1c00686","article-title":"Discovery and structure-based optimization of fragments binding the mixed lineage kinase domain-like protein executioner domain","volume":"64","author":"Rubbelke","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib192","doi-asserted-by":"crossref","first-page":"11216","DOI":"10.1021\/acs.jmedchem.3c00665","article-title":"PROTACs targeting MLKL protect cells from necroptosis","volume":"66","author":"Rathje","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib193","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/acs.jmedchem.4c00949","article-title":"Discovery of covalent MLKL PROTAC degraders via optimization of a theophylline derivative ligand for treating necroptosis","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib194","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2012.07.051","article-title":"Synthesis and biological activity evaluation of emodin quaternary ammonium salt derivatives as potential anticancer agents","volume":"56","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10637-019-00764-w","article-title":"Emodin induced necroptosis in the glioma cell line U251 via the TNF-\u03b1\/RIP1\/RIP3 pathway","volume":"38","author":"Zhou","year":"2020","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ejmech.2026.118623_bib196","doi-asserted-by":"crossref","first-page":"697","DOI":"10.5483\/BMBRep.2014.47.12.069","article-title":"Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy","volume":"47","author":"Lee","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.ejmech.2026.118623_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225716","article-title":"Celastrol induces necroptosis and ameliorates inflammation via targeting biglycan in human gastric carcinoma","volume":"20","author":"Guo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118623_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114070","article-title":"Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1\/RIP3\/MLKL pathway to induce necroptosis","volume":"229","author":"Feng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib199","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.ejmech.2011.06.004","article-title":"Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents","volume":"46","author":"Jin","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopha.2013.06.002","article-title":"Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells","volume":"67","author":"Wu","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118623_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152832","article-title":"Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy","volume":"60","author":"Mbaveng","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.118623_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113684","article-title":"Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells","volume":"171","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118623_bib203","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1021\/acs.jmedchem.1c01123","article-title":"A novel anticancer stem cell compound derived from pleuromutilin induced necroptosis of melanoma cells","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib204","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/aps.2017.112","article-title":"Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1\/RIP3 necrosome formation","volume":"38","author":"Lu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.118623_bib205","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2394584","article-title":"Shikonin from Lithospermum erythrorhizon induces pyroptosis in trophoblast cells by activating the CTSB-NLRP3 inflammasome","volume":"56","author":"Zeng","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejmech.2026.118623_bib206","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/OTT.S302334","article-title":"GDC-0326 enhances the effects of 5-Fu in colorectal cancer cells by inducing necroptotic death","volume":"14","author":"Zhang","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2026.118623_bib207","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/carcin\/bgy039","article-title":"Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1\/RIP3\/PARP-1 pathways","volume":"39","author":"Li","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2026.118623_bib208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13048-022-00984-4","article-title":"Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis","volume":"15","author":"Liu","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ejmech.2026.118623_bib209","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fonc.2018.00598","article-title":"Curaxin CBL0137 exerts anticancer activity via diverse mechanisms","volume":"8","author":"Jin","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118623_bib210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118623_bib211","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1002\/anie.201511881","article-title":"The benzyl moiety in a quinoxaline-based scaffold acts as a DNA intercalation switch","volume":"55","author":"Mahata","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.118623_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113995","article-title":"Substituent effect of benzyl moiety in nitroquinoxaline small molecules upon DNA binding: cumulative destacking of DNA nucleobases leading to histone eviction","volume":"229","author":"Pal","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116377","article-title":"Mono-quinoxaline-induced DNA structural alteration leads to ZBP1\/RIP3\/MLKL-driven necroptosis in cancer cells","volume":"270","author":"Saha","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib214","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110427","article-title":"A steroidal glycoside abrogates STAT3 signaling Cascade and exhibits anti-cancer activity by causing GSH\/GSSG imbalance in lung carcinoma","volume":"10","author":"Lee","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.118623_bib215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.phymed.2018.01.002","article-title":"Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells","volume":"40","author":"Lee","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.118623_bib216","first-page":"439","article-title":"Ophiopogonin D' induces RIPK1-dependent necroptosis in androgen-dependent LNCaP prostate cancer cells","volume":"56","author":"Lu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.118623_bib217","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1021\/acs.jmedchem.8b00900","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118623_bib218","first-page":"1627","article-title":"Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer, mol cancer ther","volume":"20","author":"Crawford","year":"2021"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:09:40Z","timestamp":1777529380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":218,"alternative-id":["S0223523426000681"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118623","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule modulators of the necroptotic pathway: A medicinal chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118623"}}